Connection
Erin Schenk to Bevacizumab
This is a "connection" page, showing publications Erin Schenk has written about Bevacizumab.
|
|
Connection Strength |
|
 |
|
 |
|
0.199 |
|
|
|
-
Franke AJ, Schenk EL. Re-ORIENT-ing antitumor immunity in EGFR-mutant non-small cell lung cancer: are antiangiogenics the key? Chin Clin Oncol. 2023 06; 12(3):31.
Score: 0.199